Coronary Artery Disease Clinical Trial
Official title:
NEXUS Registry: An Outcomes Database Which Tracks Patient -Reported Outcomes After Percutaneous Coronary Intervention for Coronary Artery Disease Along With Surgical and Subcutaneous Ablation for the Management of Atrial Fibrillation.
Information gathered from the patients via a disease specific questionnaire will be married to data from the National Cardiovascular Data Registry (NCDR®). Details will be continuously analyzed and used to direct quality of care at our center. The institution is categorized as a low-volume institution for percutaneous coronary intervention (PCI) for coronary artery disease treatment as well as surgical and endocardial ablation for the management of atrial fibrillation (Afib). The association between operator volume and quality has primarily focused on rare complications, such as mortality. The aim is to highlight the advantages of receiving care close to home. A benefit of offering the procedures to treat diseases at centers that have lower volumes is to improve patients' outcomes while also providing more convenient access to quality care. The key outcome from the patients' experience is alleviation of their symptoms while increasing function and quality of life. To date, there have been no studies documenting the health status benefits of PCI and surgical / endocardial ablation for coronary artery disease and Afib, respectively with low- volume operators. In this study, the investigators sought to examine the feasibility of implementing patient-reported outcomes into clinical care and to demonstrate evidence of benefits, from patients' perspectives, of receiving treatment by low-volume operators.
This is a prospective cohort, time series analysis of the routine procedures associated with
the catheterization and the electrophysiology lab through ten years post intervention. The
goal is to demonstrate clinical effectiveness with cardiac service line with low-volume
operators. A connection between NCDR with applied clinical research that directs continuous
quality improvement goals and objectives is the ideal setting for value-based, quality care.
The system of diagnosing, treating and tracking individuals with cardiovascular and pacing
disease has many facets which could benefit from continuous quality improvement and outcomes
analysis. The proposed Valley View NEXUS outcomes registry will bridge national data to local
clinical data. Clinical registries are a methodically sound instrument for measuring and
improving performance. Registries are efficacious for surveillance, measuring effectiveness
of quality improvement initiatives, identifying determinates of quality of life and function
while synergistically increasing the value of health care expenditures with respect to heart
disease, stroke, and arrhythmias.
The ADVARRA formerly Schulman Institutional Review Board (IRB) reviewed our protocol, and
authorized the study. Once informed consent was obtained, eligible adults scheduled for
diagnostic angiography with possible PCI completed a baseline patient reported outcome
assessment and again at designated follow-up intervals (six months and annually thereafter
for up to ten years). Due to the urgent nature of STEMI- PCI procedures, it was determined
that informed consent prior to PCI was prohibitive; however after consideration, the protocol
was amended to capture baseline assessments immediately following PCI while the patient 's
status was in hospital with use of the Seattle Angina Questionnaire (SAQ) and the Veterans
Rand 12-Item Health Survey (VR-12). The SAQ is recognized as a disease specific questionnaire
for coronary artery disease. The SAQ is a six item questionnaire that assesses patient's
function, symptoms, and satisfaction. A higher score translates to better outcomes. The VR-12
is a twelve item questionnaire used to assess quality of life. A lower score translates to a
higher quality of life in relation to a person's health and wellness. Combining data from a
disease specific questionnaire, quality of life assessment, and the NCDR's CathPCI® Registry
serves as a nexus between big data and the individual patient experience. From January 2015
through December 2017, twenty- two patients have been enrolled. Based on the data from the
first six patients to provide scores both at baseline and month six and with a study design
to have 90% power to detect a change in the overall SAQ score of 10 points at six months, it
was determined 49 patients will need to be enrolled.
The aforementioned methodology will be applied for surgical and endocardial ablations for
patients' with Afib. Presently, enrollment is open for Afib patients and data being captured
will be analyzed to determine sample size. Patients who receive intervention for management
Afib will complete the Atrial Fibrillation Effect on Quality -of-life (AFEQT) Questionnaire
and the VR-12. Again the VR-12 is a twelve item questionnaire used to assess quality of life.
A lower score translates to a higher quality of life in relation to a person's health and
wellness. The AFEQT is recognized as a disease specific questionnaire for Afib. A higher
score translates to worse symptoms and limitations in daily function associated with Afib.
Combining the outcomes metric with NCDR's Afib Ablation Registry ® allows our institution
demonstrative effective outcomes for low-volume operators.
The data validation process applies to both PCI and surgical and/or endocardial ablation and
is as follows:
1. Quality Assurance Plan Training for staff that populates both data registries is
ongoing. Staff will participate in the NCDR® applicable training modules. Documentation
of training will be maintained in the study coordinator's office. Agreeing to
participate with the NCDR®, an institution also agrees to random site monitoring and/or
audits.
2. Data Checks All patients who agree to participate in NEXUS outcomes registry and
subsequent statistical analysis will experience a complete date audit for both outcomes
assessments and NCDR® data elements. NCDR® has algorithm limits for both CathPCI®
Registry and Afib Ablation ® Registry. All registry elements require abstraction form
Meditech source documents. Reports are titled Cardiology Procedure Note and
Electrophysiology Procedure Note for PCI and Afib ablation, respectively.
Quality/outcome metrics will be sampled in paper form -the sources documents.
Information will then be populated into excel for scoring. All paper forms will be
maintained for the life of the study.
3. Data Dictionary Complete Data Dictionaries are provided by NCDR® with data element
numbers and associated limits and acceptable values for both Cath PCI ® and Afib
Ablation ® Registry.
4. Standard Operating Procedures A complete NEXUS Registry Protocol will be on site held in
the Cardiovascular Innovation & Research Institute at Valley View Hospital along with
all regulatory information, lab certifications, training documents, IRB documents,
license agreements, analytic agreements and process maps for informed consent for
outcomes research. Note NCDR® registries obtained a waiver for informed consent.
5. Sample Size Assessment The number of patients necessary to demonstrate an effect for
outcomes after PCI with low-volume operators is 49.
Presently, outcomes after surgical and/or endocardial ablation are being piloted to
determine sample size for a study powered at 90%.
6. Missing Data Every attempt will be made to reach patients to ensure they are not lost to
follow-up. Statistical consult recommends last observation carried forward for missing
data.
7. Statistical Analysis Plan. For the primary analysis, the 6-month change in mean SAQ will
be tested using a 1-sample upper 1-sided t-test. With 49 completers the t-test will have
90.4% power to detect an improvement in mean SAQ score of 10 points. A linear regression
model will be used for the secondary analysis to investigate factors which are
associated with the 6-month change (month 6 - baseline) in mean SAQ score. Factors which
will be investigated for inclusion in the model include sex, age, physician American
Society Anesthesiologists (ASA) class, physician volume, access site, and Charlson
comorbidity index. An all-possible regressions approach will be used during the model
building process in which all possible regression models are fit. The models will then
be evaluated using Mallows' Cp statistic where models with values of Cp less than p (the
number of parameters) will be considered as strong candidates for the final model. The
final model will be selected after considering both results from the model selection
process and subject matter knowledge. The regression analysis will have greater power
than the t-test used in the sample size justification due to the reduction in
variability of the outcome measure by including additional factors in a regression
model. Additional analyses include [need to add specifics here]. All analyses will be
conducted using SAS 9.4M4 or greater software (SAS Institute, Inc., Cary, NC, USA).
Morbidity / Complications will be reported included but not limited to bleeding at access
site, hematoma, cardiac tamponade, vascular perforation, peripheral vascular injuries, post
procedure hematoma, and mortality.
Statistical Analysis Plan with Respect to Surgical and/ or Endocardial Ablation for Afib
This outcomes registry is in its early pilot analysis for Afib and hypothesis generating. For
the primary analysis, the six-month change in mean AFEQT scores will be analyzed.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06030596 -
SPECT Myocardial Blood Flow Quantification for Diagnosis of Ischemic Heart Disease Determined by Fraction Flow Reserve
|
||
Completed |
NCT04080700 -
Korean Prospective Registry for Evaluating the Safety and Efficacy of Distal Radial Approach (KODRA)
|
||
Recruiting |
NCT03810599 -
Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study
|
N/A | |
Recruiting |
NCT06002932 -
Comparison of PROVISIONal 1-stent Strategy With DEB Versus Planned 2-stent Strategy in Coronary Bifurcation Lesions.
|
N/A | |
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Recruiting |
NCT04242134 -
Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions
|
N/A | |
Recruiting |
NCT05308719 -
Nasal Oxygen Therapy After Cardiac Surgery
|
N/A | |
Completed |
NCT04556994 -
Phase 1 Cardiac Rehabilitation With and Without Lower Limb Paddling Effects in Post CABG Patients.
|
N/A | |
Recruiting |
NCT05846893 -
Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease
|
N/A | |
Recruiting |
NCT06027788 -
CTSN Embolic Protection Trial
|
N/A | |
Recruiting |
NCT05023629 -
STunning After Balloon Occlusion
|
N/A | |
Completed |
NCT04941560 -
Assessing the Association Between Multi-dimension Facial Characteristics and Coronary Artery Diseases
|
||
Completed |
NCT04006288 -
Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease
|
Phase 4 | |
Completed |
NCT01860274 -
Meshed Vein Graft Patency Trial - VEST
|
N/A | |
Recruiting |
NCT06174090 -
The Effect of Video Education on Pain, Anxiety and Knowledge Levels of Coronary Bypass Graft Surgery Patients
|
N/A | |
Terminated |
NCT03959072 -
Cardiac Cath Lab Staff Radiation Exposure
|
||
Completed |
NCT03968809 -
Role of Cardioflux in Predicting Coronary Artery Disease (CAD) Outcomes
|
||
Recruiting |
NCT05065073 -
Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography
|
Phase 4 | |
Recruiting |
NCT04566497 -
Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up.
|
N/A | |
Completed |
NCT05096442 -
Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions
|
N/A |